These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31512064)

  • 1. Persistence of High In Vivo Efficacy and Safety of Artesunate-Amodiaquine and Artemether-Lumefantrine as the First- and Second-Line Treatments for Uncomplicated Plasmodium falciparum Malaria 10 Years After Their Implementation in Gabon.
    Ndong Ngomo JM; Ondzagha Megnie GJ; Moutombi Ditombi B; Koumba Lengongo JV; M'Bondoukwé NP; Offouga CL; Mawili-Mboumba DP; Lekana-Douki JB; Ringwald P; Fandeur T; Bouyou-Akotet MK
    Acta Parasitol; 2019 Dec; 64(4):898-902. PubMed ID: 31512064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.
    Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA
    Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo efficacy and safety of artemether-lumefantrine and amodiaquine-artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018.
    Nhama A; Nhamússua L; Macete E; Bassat Q; Salvador C; Enosse S; Candrinho B; Carvalho E; Nhacolo A; Chidimatembue A; Saifodine A; Zulliger R; Lucchi N; Svigel SS; Moriarty LF; Halsey ES; Mayor A; Aide P
    Malar J; 2021 Oct; 20(1):390. PubMed ID: 34600544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
    Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
    Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique.
    Nhama A; Bassat Q; Enosse S; Nhacolo A; Mutemba R; Carvalho E; Naueia E; Sevene E; Guinovart C; Warsame M; Sanz S; Mussa A; Matsinhe G; Alonso P; Tiago A; Macete E
    Malar J; 2014 Aug; 13():309. PubMed ID: 25108397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015-2017.
    Abuaku B; Duah-Quashie NO; Quaye L; Matrevi SA; Quashie N; Gyasi A; Owusu-Antwi F; Malm K; Koram K
    Malar J; 2019 Jun; 18(1):206. PubMed ID: 31234874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine].
    Sow D; Ndiaye JL; Sylla K; Ba MS; Tine RC; Faye B; Pene M; Ndiaye M; Seck A; Lo AC; Abiola A; Dieng Y; Gaye O
    Med Sante Trop; 2016; 26(1):45-50. PubMed ID: 26644184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014.
    Paczkowski M; Mwandama D; Marthey D; Luka M; Makuta G; Sande J; Ali D; Troell P; Mathanga DP; Gutman J
    Malar J; 2016 Apr; 15():236. PubMed ID: 27113085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
    Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
    Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
    Davlantes E; Dimbu PR; Ferreira CM; Florinda Joao M; Pode D; Félix J; Sanhangala E; Andrade BN; Dos Santos Souza S; Talundzic E; Udhayakumar V; Owens C; Mbounga E; Wiesner L; Halsey ES; Martins JF; Fortes F; Plucinski MM
    Malar J; 2018 Apr; 17(1):144. PubMed ID: 29615039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance.
    Issa MS; Warsame M; Mahamat MHT; Saleh IDM; Boulotigam K; Djimrassengar H; Issa AH; Abdelkader O; Hassoumi M; Djimadoum M; Doderer-Lang C; Ndihiokubwayo JB; Rasmussen C; Menard D
    Malar J; 2023 Aug; 22(1):240. PubMed ID: 37612601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.
    Nji AM; Ali IM; Moyeh MN; Ngongang EO; Ekollo AM; Chedjou JP; Ndikum VN; Evehe MS; Froeschl G; Heumann C; Mansmann U; Ogundahunsi O; Mbacham WF
    Malar J; 2015 Jan; 14():27. PubMed ID: 25626448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2019.
    Ngasala BE; Chiduo MG; Mmbando BP; Francis FT; Bushukatale S; Makene T; Mandara CI; Ishengoma DS; Kamugisha E; Ahmed M; Mahende MK; Kavishe RA; Muro F; Molteni F; Reaves E; Kitojo C; Greer G; Nyinondi S; Kabula B; Lalji S; Chacky F; Njau RJ; Warsame M; Mohamed A
    Malar J; 2024 Apr; 23(1):101. PubMed ID: 38594679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial.
    Djallé D; Njuimo SP; Manirakiza A; Laganier R; Le Faou A; Rogier C
    Malar J; 2014 Jan; 13():9. PubMed ID: 24393479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018.
    Dentinger CM; Rakotomanga TA; Rakotondrandriana A; Rakotoarisoa A; Rason MA; Moriarty LF; Steinhardt LC; Kapesa L; Razafindrakoto J; Svigel SS; Lucchi NW; Udhayakumar V; Halsey ES; Ratsimbasoa CA
    Malar J; 2021 Nov; 20(1):432. PubMed ID: 34732201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo.
    Lula Ntamba Y; Muhindo Mavoko H; Kalabuanga M; Fungula B; Ntamabyaliro Nsengi PM; Tona Lutete G; Inocencio da Luz R; Van Geertruyden JP; Lutumba P
    PLoS One; 2019; 14(9):e0222379. PubMed ID: 31527899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaoundé, Cameroon: a randomized trial.
    Niba PTN; Nji AM; Ali IM; Akam LF; Dongmo CH; Chedjou JPK; Fomboh CT; Nana WD; Oben OLA; Selly-Ngaloumo AA; Moyeh MN; Ngu JA; Ludovic AJ; Aboh PM; Ambani MCE; Omgba PAM; Kotcholi GB; Adzemye LM; Nna DRA; Douanla A; Ango Z; Ewane MS; Ticha JT; Tatah FM; Dinza G; Ndikum VN; Fosah DA; Bigoga JD; Alifrangis M; Mbacham WF
    BMC Infect Dis; 2022 Feb; 22(1):166. PubMed ID: 35189818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial.
    Beavogui AH; Camara A; Delamou A; Diallo MS; Doumbouya A; Kourouma K; Bouedouno P; Guilavogui T; Dos Santos Souza S; Kelley J; Talundzic E; Fofana A; Plucinski MM
    Malar J; 2020 Jun; 19(1):223. PubMed ID: 32580771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety and Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine in Niger].
    Ibrahima I; Laminou IM; Adehossi E; Maman D; Boureima S; Harouna HK; Hamidou HH; Mahamadou A; Yacouba I; Hadiza J; Tidjani IA
    Bull Soc Pathol Exot; 2020; 113(1):17-23. PubMed ID: 32881447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.
    Adjei GO; Kurtzhals JA; Rodrigues OP; Alifrangis M; Hoegberg LC; Kitcher ED; Badoe EV; Lamptey R; Goka BQ
    Malar J; 2008 Jul; 7():127. PubMed ID: 18620577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.